Search the Newsreel

Sagility India's Q1 profit jumps 46% as revenue grows, client base expands

Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now?

Agilent Technologies recently received FDA approval for its PD-L1 IHC 28-8 pharmDx assay, strengthening its position in precision oncology diagnostics. Despite this, its share price is down 5.6% year-to-date, though analysts and intrinsic value models suggest the stock is undervalued by over 20% compared …

Michael Buckner Joins Agilent Technologies as Chief Legal Officer

Agilent Technologies Inc. has appointed Michael Buckner as its new chief legal officer. Buckner brings nearly three decades of experience as a senior global legal executive, having previously served as vice president, deputy general counsel, and chief M&A counsel at Danaher Corp. His appointment …

HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited

HALO X-ray Technologies Ltd has successfully closed a multimillion-dollar funding round led by new investor Agilent Technologies, Inc. Returning investors included UK Innovation & Science Seed Fund, managed by Future Planet Capital, and Midlands Engine Investment Fund, co-managed by British Business Investments Ltd. and …

Agilent Increases Its Investment in HALO X-ray Technologies

Agilent Technologies Inc. has led a multimillion-dollar investment round in HALO X-ray Technologies, with existing investors UK Innovation Science Seed Fund (UKI2S) and the Midland Engine Investment Fund (MEIF) also participating. This funding will allow HALO to complete regulatory approval for its advanced security …

Buy, Sell Or Hold: Ashok Leyland, Canara Bank, Trent, Vedanta Steel And Sagility — Ask Profit

agilon health (AGL) Proxy filing Summary

agilon health (AGL) has released its proxy filing summary, detailing the upcoming annual meeting on June 2, 2026. Shareholders will vote on electing three Class II directors, ratifying Ernst & Young LLP as auditor, and an advisory vote on executive compensation, all of which …

Agilent Technologies (A) Q2 2025 earnings summary

Agilent Technologies reported Q2 FY2025 revenue of $1.67 billion, a 6% year-over-year increase, surpassing expectations. Non-GAAP EPS rose by 7% to $1.31, while GAAP EPS declined by 29% to $0.75 due to lower margins and higher restructuring costs. The company raised its FY2025 revenue …

Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuation

Agilent Technologies' stock shows stable sentiment, driven by recent fiscal Q2 2026 earnings, margin trends, and consistent demand from life sciences and diagnostics customers. The company's financial performance highlights billions in revenue, sustained profitability, and strong cash generation, which underpin its current market capitalization. …

agilon Health (AGL) Stock Looks Undervalued On Sales But Rich After A 7x Run

agilon health (AGL) has seen a significant 671% return year-to-date, but despite this, Simply Wall St's analysis suggests the stock remains undervalued based on sales multiples. The company's P/S ratio (0.4x) is well below the industry average, indicating that the market might be cautious …

Agilent Technologies (A) Proxy Filing Summary

Agilent Technologies has released a proxy filing summary ahead of its annual meeting on March 18, 2026. Key items for shareholder voting include the election of four directors, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as the independent accounting firm, and …

Agilent Technologies stock holds support as results stay in focus

The article discusses Agilent Technologies (ISIN US00846U1016) stock, emphasizing that investor attention remains focused on the company's latest reported financial figures, including revenue, margin, and cash flow. Without a fresh market update or dated quote, the analysis relies on the company's prior operating and …

Agilent 1260 Infinity II LC by Agilent Technologies Inc. - mid-range workhorse for routine labs

The Agilent 1260 Infinity II LC is highlighted as a mid-range, modular liquid chromatograph designed for routine analytical labs in pharmaceutical, chemical, and food industries. It offers high-throughput capabilities with up to 600 bar pressure, scalability, and robust performance for stable retention times and …

Agilysys Inc (AGYS) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100

Agilysys Inc (AGYS) shares fell 3.1% to $106.59 but are considered undervalued with a GF Value™ estimate of $120.26, indicating a potential 11.4% margin of safety. The stock has a strong GF Score™ of 80/100, driven by excellent financial strength and valuation, despite low …

Agilent Technologies Inc (A) Stock Down 3.4% -- Now Undervalued? GF Score: 93/100

Agilent Technologies Inc (A) shares dropped 3.4% to $131.46, but GuruFocus's GF Value™ indicates the stock is 9.9% undervalued at $145.87. Despite a strong GF Score™ of 93/100, insider selling worth $0.2M in the last three months suggests caution. The current P/E ratio is …

Agilent Technologies Inc. stock underperforms Friday when compared to competitors

Agilent Technologies Inc. (A) stock fell 3.41% on Friday to $131.46, underperforming the broader market as the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) also saw declines. This puts Agilent Technologies Inc. 17.98% below its 52-week high of $160.27, which was …

Agilent Technologies stock extends focus on earnings and valuation

This article discusses how Agilent Technologies' stock performance remains tied to its latest earnings, valuation, and market context. It emphasizes that a comprehensive market analysis, including dated operating figures and market values, cannot be provided due to the lack of current live financial data, …

Agilysys Jumps 5.1% Amid Sector-Wide Rally

Agilysys, Inc. (AGYS) saw a 5.1% increase, closing at $111.97, driven by a sector-wide rally that boosted software application stocks. This gain was part of a broader trend where several of its peers also experienced significant jumps, suggesting institutional money is rotating into the …

AG8A Bond Profile — Key Metrics

This article provides a bond profile for Agilent Technologies, Inc.'s AG8A bond, highlighting key metrics such as a 2.3% coupon rate and a maturity date of March 12, 2031. It details the company's operations across its Life Sciences and Diagnostics Markets, Applied Markets, and …

Agilysys Inc (AGYS) heads toward July 20 earnings with a 25-cent estimate

The hospitality-software stock enters the event with short-term softness set against a much stronger multiweek tape.

Agilysys (AGYS) Proxy filing Summary

This article summarizes the proxy filing for Agilysys (AGYS), announcing its annual meeting on September 2, 2026, to be held virtually. Shareholders will vote on the election of eight directors, executive compensation, and the ratification of Grant Thornton LLP as the independent auditor. The …

Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $141

Wells Fargo has reiterated its "Buy" rating for Agilon Health (AGL.US), maintaining a price target of $141. This indicates the firm's continued positive outlook on the company's stock performance.

Agilysys (AGYS) Posts Record Revenue, Is It Still 16% Below Fair Value?

Agilysys (AGYS) recently reported its 17th consecutive quarter of record revenue, attracting investor attention. While Simply Wall St suggests the stock is 16.4% undervalued with a fair value of $127.33 due to its shift to a SaaS model and recurring revenue, its high P/E …

Agilon Health (AGL) Rallies On AI Care Narrative As Valuation Questions Linger

Agilon Health (AGL) has seen a recent surge in share price, leading investors to re-evaluate its Medicare-focused model and financial metrics, with analysts suggesting an AI care narrative is driving the rally. Despite a 130.2% one-year return, the stock is considered overvalued by many, …

(AGYS) Price Dynamics and Execution-Aware Positioning

This article analyzes Agilysys Inc. (NASDAQ: AGYS) price dynamics, indicating near-term weak sentiment but mid-term strength within a long-term weak bias. It identifies no resistance levels above the current price, suggesting upside potential. The report also outlines institutional trading strategies based on AI models, …

Agilon health stock hits 52-week high at 126.0 USD

Agilon Health Inc. stock reached a 52-week high of $125.71, currently trading at $125.66, reflecting a year-to-date return of 612% and a one-year gain of 123%. Despite trading with high price volatility, InvestingPro analysis suggests the stock remains undervalued relative to its Fair Value. …

Agilysys (AGYS) Among the Best Growth Stocks To Buy and Hold

Dividend: Sagility Ltd Dividend History

Agilysys (AGYS) Q4 Fiscal 2026 Earnings: Revenue Up 11.7%, AI Boosts Margins - News and Statistics

Agilysys (AGYS) Reports Q4 Earnings: What Key Metrics Have to Say

Agilysys (AGYS) Q4 Earnings and Revenues Surpass Estimates

Agilysys (NASDAQ:AGYS) Posts Better-Than-Expected Sales In Q1 CY2026, Stock Jumps 11%

AGILYSYS Q4 2026 Earnings Preview: Recent $AGYS Insider Trading, Hedge Fund Activity, and More

Sagility FY26 Net Profit Rises 71.5% to ₹9,248M

Sagility India's Shares May Rally 32% Says Motilal Oswal Post Strong Q4 Results — Check Target Price

Sagility Q4 net profit climbs 41%, revenue up 29%; declares dividend